National Harbor, MD, 7 - 8 September 2022

Schedule

Create your personal agenda –check the favourite icon

Sep 78:55 AM
Conference pass

Opening remarks: Conference Chair

Keynotes
Henry Skinner, CEO, AMR Action Fund
Sep 79:00 AM
Conference pass

Keynote Address: Reserved for US Legislator

Keynotes

Policymaker to be announced

Sep 79:40 AM
Conference pass

Keynote Panel: Global call to action to further combat AMR

Keynotes
Henry Skinner, CEO, AMR Action Fund
Kevin Outterson, Professor, Boston University, Executive Director, CARB-X
Diane Shader Smith, AMR Advocate and Author, -
Ricardo Chaves, Executive Medical Director Infectious Diseases, Debiopharm
Sep 711:20 AM
Conference pass

Antibiotic Development: What does the future hold?

Antibiotic Development
Michele Dilizia, Vice President & Chief Scienti, Recce Pharmaceuticals
Sep 711:20 AM
Conference pass

Antibiotic stewardship & the role of pharmacists

Antibiotic Stewardship

Speaker to be announced

Sep 711:20 AM
Conference pass

Diagnostic innovation to fight AMR, building up on COVID-19 efforts

Diagnostics
Kavi Ramjeet, Head of Business Intelligence, FIND the global alliance for diagnostics
Sep 711:20 AM
Conference pass

Panel: Current investor sentiment & outlook for funding in the antimicrobial resistance space

Innovation Showcase
Moderator: Marc Gitzinger, Vice President, Beam Alliance
Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Phil Packer,  Innovation Lead AMR and Vaccines, Innovate UK
Erin Duffy, R&D Chief, CARB-X
Sep 711:20 AM
Conference pass

SECURE – the future antibiotic facility to accelerate access to essential antibiotics

Antibiotic Commercialization
Yann Ferrisse, Head of Business Development, GARDP Foundation
Sep 711:40 AM
Conference pass

Building the next generation of infectious disease pharmacists

Antibiotic Stewardship
Melissa Johnson, Associate Professor of Medicine and Liaison Clinical Pharmacist, Duke University Medical Center
Sep 711:40 AM
Conference pass

Future outlook on Combined influenza and COVID-19 vaccines

Vaccines

Speaker to be announced

Sep 711:40 AM
Conference pass

Health data sharing to better understand patient experience & history 

Genomics & Surveillance
Jon Glaudemans, Executive Director of National Sepsis Data Trust Initiative, Sepsis Alliance
Sep 711:40 AM
Conference pass

PANEL: Efforts and Value: New data ecosystems to battle infectious diseases

Diagnostics

Speakers to be announced

Moderator: Steve Kearney, Global Medical Director, SAS
Hsiu Wu, Lead, NHSN Antimicrobial Use a, CDC
Gabriel Pedone, AMR Business Manager, Biomerieux INC
Sep 711:40 AM
Conference pass

Panel: Pathogen-specific antibiotic therapy: A new paradigm to face AMR?

Antibiotic Development

Speakers to be announced

Ricardo Chaves, Executive Medical Director Infectious Diseases, Debiopharm
James Anderson ​, Executive Director Global Heal, IFPMA
Vance Fowler, Professor of Medicine, Duke University Medical Center
Sep 711:40 AM
Conference pass

Panel: Sustainable access for existing antibiotics: Focus on Market Challenges

Antibiotic Commercialization
Yann Ferrisse, Head of Business Development, GARDP Foundation
Mirfin Mpundu, Director, React Africa
Moska Hellamand, Lead researcher in AMR, Access to Medicine Foundation
Boumediene Soufi, Global Head AMR, Sandoz
Nicholas Adomakoh, Global Medial Affairs Lead, Sandoz
Sep 712:00 PM
Conference pass

Ibezapolstat Update: In Ph2 Clinical Development for C. difficile Infection

Innovation Showcase
Robert Deluccia, Executive Chairman, Acurx Pharmaceuticals
Sep 712:00 PM
Conference pass

Panel: Addressing stewardship within community hospitals

Antibiotic Stewardship
Moderator: Elizabeth Dodds Ashley, Associate Professor of Medicine with the Division of Infectious Diseases and International Health, Duke University
Marc Meyer, Director of Pharmacy Services, Infection Control, Southwest Health System
Sep 712:00 PM
Conference pass

Panel: Genomics for global AMR surveillance: challenges and opportunities

Genomics & Surveillance
Moderator: Anita Suresh, Deputy Director of Genomics & Sequencing, FIND the global alliance for diagnostics
Wes Kim, Assistant Director of Global Public Health Programs, American Society for Microbiology
Leonid Chindelevitch, Infectious Disease Lecturer, Imperial College London
Sep 712:10 PM
Conference pass

Panel: Collaboration for access in high impact countries – bringing products and tools to the right patient, place, and problem

Antibiotic Commercialization
Moderator: Anand Anandkumar, Chief Executive Officer, Bugworks Research
Gareth Morgan, Senior Vice President, Head, Global Portfolio Management, Shionogi inc
Ghada Zoubiane, Head of Partnerships and Stake, International Centre for AMR solutions
Jaideep Gogtay, Chief Medical Officer, Cipla
Jean-Pierre Paccaud, Director BD, Jean-Pierre Paccaud
Valeria Gigante, Team Lead, World Health Organization
David Ripin, EVP, Infectious Diseases & Chief Science Officer, Clinton Health Access Initiative, Inc.
Sep 712:10 PM
Conference pass

Panel: New therapeutics and agents in decolonization

Antibiotic Development
John Jernigan, Chief, Epidemiology Research, and Innovations Branch, Centers for Disease Control and Prevention
Peter Kim, Clinical Team Leader, CBER, Food and Drug Administration (FDA)
Susan Huang, Professor, University of California, Irvine
Sep 712:20 PM
Conference pass

Pravibismane: A Phase 2 Compound in a Novel Class Enabling a Novel Approach to Overcome AMR

Innovation Showcase
Karim Lalji, CEO, Microbion Pharma Corp.
Sep 712:40 PM
Conference pass

Film Screening in Expo Hall: Beating Superbugs Better: Can We Win?

Film Screenings
Bill Mudge, Director/ Co-Producer, Recombinant Films
Jean Mudge, Scriptwriter/ Co-Producer, Recombinant Films
Sep 71:40 PM
Conference pass

ROUNDTABLE 1: Prioritizing Responsible antibiotics use: How to make it happen?

Roundtables
Najy Alsayed, Head of Disease Area, Infectious Diseases, Menarini Group
Sep 71:40 PM
Conference pass

ROUNDTABLE 2: Sponsored by Abbott

Roundtables

Moderators to be announced

Sep 71:40 PM
Conference pass

ROUNDTABLE 3: Lack of Access: Impact & Solutions from patient & market Perspectives

Roundtables

Moderators to be announced

Nicholas Adomakoh, Global Medial Affairs Lead, Sandoz
Boumediene Soufi, Global Head AMR, Sandoz
Sep 71:40 PM
Conference pass

ROUNDTABLE 4: SPONSORSHIP AVAILABLE

Roundtables

Sponsorship available

Sep 71:40 PM
Conference pass

ROUNDTABLE 5: Messaging for scientists: how can the scientific community better communicate important pandemic-related information to the public

Roundtables
Sep 71:40 PM
Conference pass

ROUNDTABLE 6: Strengthening global laboratory systems to fight AMR

Roundtables
Wes Kim, Assistant Director of Global Public Health Programs, American Society for Microbiology
Sep 71:40 PM
Conference pass

ROUNDTABLE 7: Global threat of AMR to child survival, growth, and development

Roundtables
Alexandre Costa, Diagnostics Adviser / AMR focal point, UNICEF
Sep 71:40 PM
Conference pass

ROUNDTABLE 8: Traditional Vs Novel: Patient perspective on traditional antibiotics vs novel therapeutics

Roundtables
Mary Millard, Patient Advocate, Sepsis Survivor
Sep 71:40 PM
Conference pass

ROUNDTABLE 9: Working on AMR in outpatient settings - irrational use and misuse

Roundtables
Danjuma Adda, AMR Patient Alliance
Sep 72:30 PM
Conference pass

How to keep patient outcomes and benefit in the heart of our objectives

Antibiotic Development
Najy Alsayed, Head of Disease Area, Infectious Diseases, Menarini Group
Sep 72:30 PM
Conference pass

Implementation and benefits of tele-stewardship

Antibiotic Stewardship
Matt Davis, Tele-stewardship pharmacist, Infectious Disease Connect
Sep 72:30 PM
Conference pass

Meta analysis of RNA data for therapeutic development

Therapeutics
Angela Zhou, Scientific Content Creation and Development Supervisor, American Chemical Society
Sep 72:30 PM
Conference pass

Panel: Regulatory pathways for phage approaches

Innovation Showcase

Speakers to be announced

Paul Garofolo, Chief Executive Officer, Locus Biosciences, Inc.
Sep 72:30 PM
Conference pass

Panel: The role of Next-Generation DNA Sequencing in antimicrobial stewardship

Diagnostics
Moderator: Christopher Bland, Clinical and Administrative Pharmacy, University of Georgia
James Snyder, Professor Department of Pathology and Laboratory Medicine and Chief of Microbiology, University of Louisville
Javad Parvizi, Professor of Orthopaedic Surgery, Sidney Kimmel School of Medicine
Clifford Martin, Assistant Clinical Professor of Medicine, University of Arizona
Sep 72:40 PM
Conference pass

Fireside Chat: Using patient empowerment and patient-centered care to address AMR

Antibiotic Development

Panelists to be announced

Mary Millard, Patient Advocate, Sepsis Survivor
Sep 72:50 PM
Conference pass

Fireside Chat: Using patient empowerment and patient-centered care to address AMR

Antibiotic Development
Moderator: Thomas Heymann, Executive Director, Sepsis Alliance
Mary Millard, Patient Advocate, Sepsis Survivor
Jimena Werner Sunderland, Founder, Latinxs against AMR
Sep 72:50 PM
Conference pass

Novel diagnostic technologies for detection and antimicrobial susceptibility testing for blood stream infections in children

Antibiotic Stewardship
Benjamin Liu, Assistant Director of Microbio, Children’s National Hospital/George Washington Univ
Sep 72:50 PM
Conference pass

Session title to be announced

Therapeutics

Sponsored by Adaptive Biotechnologies

Sep 73:10 PM
Conference pass

Panel: Moving the ball on awareness: education and action with the public, AMR stakeholders, and policy makers

Antibiotic Development
Moderator: Emily Wheeler, Director, Infectious Disease Policy, Biotechnology Innovation Organization (BIO)
Amanda Jezek, Senior Vice President, Public Policy And Government Relations, Infectious Diseases Society of America
Diane Flayhart, Global Program Leader, Amr, Becton Dickinson
Carriayne Jonesparr, Head of US Southeast Region, UK Science and Innovation Network
Thomas Heymann, Executive Director, Sepsis Alliance
Sep 73:10 PM
Conference pass

Panel: Sponsored by Cepheid

Diagnostics

Speakers to be announced

Kim Chapin-Robertson, Chief Medical Officer, Cepheid
Cristina Baker, Director of Medical Affairs, Cepheid
Jennifer L. Rakeman, Senior Director, Public Health, Cepheid
Sep 73:10 PM
Conference pass

Session title to be announced

Innovation Showcase

Sponsored by Technophage

Sep 73:30 PM
Conference pass

Bench to Bedside in 5 Months: Disrupting failed antibiotic development timelines with an adaptive closed-loop approach to AMR

Innovation Showcase
Greg Merril, Chief Executive Officer, Adaptive Phage Therapeutics
Sep 73:30 PM
Conference pass

Detection of ESBLs in the clinical laboratory

Antibiotic Stewardship
April Bobenchik, Medical Director Microbiology, Associate Professor Pathology, Penn State Hershey Medical Center
Sep 73:30 PM
Conference pass

Panel: Antimicrobials' market failures and international collaboration: Linking up with Health Systems

Antibiotic Commercialization
Moderator: Riko Kimoto, Senior Project Manager, Asia-Europe Foundation
Gerald Bloom, Professional Fellow, Institute of Development Studies
Monika Schneider, Director, Global AMR Policy, Shionogi, Inc

Create your personal agenda –check the favourite icon

Sep 88:35 AM
Conference pass

Chairperson’s opening remarks

Keynotes
Jomana Musmar, Senior Public Health Advisor, PACCARB
Sep 88:40 AM
Conference pass

Keynote Address: COVID, Monkeypox and AMR - Examining the stressors on the US healthcare system and solutions to protect patients

Keynotes
Daniel Mcquillen, President, Infectious Diseases Society of America IDSA
Sep 89:00 AM
Conference pass

Keynote Address: Session title to be announced

Keynotes
Xavier Becerra, Secretary, U.S. Department of Health & Human Services
Sep 89:20 AM
Conference pass

Keynote Address: Leveraging diagnostics to bridge pandemic-associated antimicrobial stewardship gaps

Keynotes

Speaker to be announced

Brian Raux, Medical Science Liaison, Biomerieux
Sep 89:40 AM
Conference pass

Keynote Panel: Preparedness, health security, and AMR in a post-COVID landscape

Keynotes
Moderator: Jomana Musmar, Senior Public Health Advisor, PACCARB
Michael Craig, Senior Advisor For Antibiotic Resistance, Antibiotic Resistance Coordination And Strategy Unit, Centers for Disease Control and Prevention
Fred Tenover, VP of Scientific Affairs, Cepheid
Daniel Bausch, Senior Director, Emerging Threats & Global Health Security President, FIND the global alliance for diagnostics
Sarah Despres, Counselor for Public Health and Science, U.S. Department of Health & Human Services
Sep 811:00 AM
Conference pass

Effects on MDR: co-infection in critically ill patients

Infection Prevention & Control
Angella Browne, Infection Control Officer, Howard University Hospital
Sep 811:00 AM
Conference pass

ERADICATE – a phase 3 study in complicated Staphylococcus aureus bacteremia comparing ceftobiprole with daptomycin

Antibiotic Development
Mark Jones, Head of Preclinical Development, Basilea Pharmaceutica Ltd
Sep 811:00 AM
Conference pass

Panel: AMR Innovation in the UK: Synergies and opportunities for international collaboration

Global Highlight: UK
Robin Cohen, Chief Commercial Officer, Emergex Vaccines
Alwyn Hart, Lead Scientist, Environment Agency UK Government
Deborah O'Neil, Chief Executive Officer, NovaBiotics Ltd
Phil Packer,  Innovation Lead AMR and Vaccines, Innovate UK
Simon Doherty, Senior Lecturer, Queen’s University Belfast
Mandy Nevel, Head of Animal Health and Welfare, Agriculture and Horticulture Development Board (ADHB)
Sep 811:00 AM
Conference pass

Re-inventing antimicrobial agents using CRISPR technology

Innovation Showcase
Milan Zdravkovic, CMO, Head of R&D, SNIPR BIOME
Sep 811:00 AM
Conference pass

The role of vaccines in reducing antimicrobial resistance

Vaccines (AMR)
Shelley Magill, Division of Healthcare Quality Promotion, CDC
Sep 811:20 AM
Conference pass

Session title to be announced

Innovation Showcase
Ken Blount, chief scientific officer, Rebiotix, a Ferring Company
Sep 811:20 AM
Conference pass

Session title to be announced

Infection Prevention & Control

Speaker to be announced

Sep 811:20 AM
Conference pass

Session title to be announced

Vaccines (AMR)
Ed Buurman, Director Alliances, CARB-X
Sep 811:20 AM
Conference pass

Setting up a company in the AMR space – considerations for operations, structure, and market opportunities

Antibiotic Commercialization
David Findlay, Co Founder and Chief Executive Officer, Rosa Therapeutics Ltd
Sep 811:40 AM
Conference pass

Monkeypox: Tackling multiple infection prevention & control protocols

Infection Prevention & Control

Speaker to be announced

Sep 811:40 AM
Conference pass

One Drug for One Bug: Fabl Novel Class Antibiotics for Microbiome Sparing and AMR Prevention

Innovation Showcase

Speaker to be announced

Riccardo NIsato, Licensing and Grants Associate Manager, Debiopharm International SA
Mohammed Benghezal, Global Project Lead, Debiopharm International
Sep 811:40 AM
Conference pass

Panel: Addressing the urgent need for incentives and funding

Antibiotic Commercialization
Mark Albrecht, Branch Chief - Antibacterials Program, BARDA
Lesley Ogilvie, Senior Scientific Programme Of, Global AMR R&D Hub
Amanda Horstman-Smith, Science and Technology Manager, Defense Threat Reduction Agency
Sep 811:40 AM
Conference pass

Panel: Avoiding hurdles in clinical development

Antibiotic Development
Moderator: Monique Van Hoek, Professor, George Mason University, College of Science
Michael Dudley, President, Chief Executive Officer and Co-founder, Qpex Biopharma
Aleksandar Danilovski, Chief Scientific Officer, Xellia Pharmaceuticals
Peter Jackson, Executive Officer, Infex Therapeutics
Sep 811:40 AM
Conference pass

Panel: Session title to be announced

Vaccines (AMR)

Speakers to be announced

Sep 812:20 PM
Conference pass

Film Screening in Expo Hall: Screening: Salt in my Soul

Film Screenings
Diane Shader Smith, AMR Advocate and Author, -
Sep 81:40 PM
Conference pass

ROUNDTABLE 1: Utilization of Next-Generation Sequencing in Infectious Disease Diagnostics

Roundtables
Christopher Bland, Clinical and Administrative Pharmacy, University of Georgia
Sep 81:40 PM
Conference pass

ROUNDTABLE 12: Antibiotic Launches: Differentiating in a Non-Inferiority World

Roundtables
Rolf Wagenaar, Principal, CD&E Consulting LLC
Sep 81:40 PM
Conference pass

ROUNDTABLE 2: One health: community engagement against AMR

Roundtables
Jimena Werner Sunderland, Founder, Latinxs against AMR
Frida Romay Hidalgo, Founder, Latinxs against AMR
Sep 81:40 PM
Conference pass

ROUNDTABLE 3: From the ground up: building a comprehensive understanding of AMR amongst the next generation of leaders

Roundtables
Anna Govett, Programme Lead, Future Leaders Against AMR
Sep 81:40 PM
Conference pass

ROUNDTABLE 4: Addressing the market failures for antimicrobials using a health system approach: A message for the 2023 G7 Summit

Roundtables
Riko Kimoto, Senior Project Manager, Asia-Europe Foundation
Sep 81:40 PM
Conference pass

ROUNDTABLE 5: Catalyzing co-ordination and collaboration in AMR research and development

Roundtables
Lesley Ogilvie, Senior Scientific Programme Of, Global AMR R&D Hub
Sep 81:40 PM
Conference pass

ROUNDTABLE 6: Session title to be announced - Sponsored by Centrient Pharmaceuticals

Roundtables

Moderator to be announced

Sep 82:10 PM
Conference pass

Novel approaches in direct acting small molecules

Antibiotic Development
Andrew Tomaras, Chief Scientific Officer, Forge Therapeutics
Sep 82:10 PM
Conference pass

Panel: Microbiome Therapeutics: From Concept to Reality in AMR

Innovation Showcase
Moderator: Natalie D'Amore, Head of External Innovation, Seres Therapeutics Inc
Sheila Miknyoczki, Project Officer, BARDA
Dan Freedberg, Assistant Professor, Columbia University
Denise Kelly, Advisor - Microbiome Expert, Seventure
Matthew Henn, EVP, Chief Scientific Officer, Seres Therapeutics Inc
Sep 82:30 PM
Conference pass

Annual review of antibacterial agents in clinical and preclinical development

Antibiotic Development
Valeria Gigante, Team Lead, World Health Organization
last published: 11/Aug/22 15:35 GMT

 


GET INVOLVED AT THE

WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Semen Sen

semen.sen@terrapinn.com
+1 646.619.1793

 

 

To Speak

 


Emma Goaley

emma.goaley@terrapinn.com
+1 646.400.2576

 

 

Press & Media Partnerships

 


Ipek Coskun

ipek.coskun@terrapinn.com
+1 407.421.5818